ISRCTN26791028[Secondary Source ID] - Search Results

Year	Number of Results
2009	1
2012	1
2013	1
2014	2
2018	1
2021	1
2025	0

1

Comparing cost-utility of DMARDs in autoantibody-negative rheumatoid arthritis patients.

Nathalie LM, Mulligen VE, Maria WAEA, Wilhelmina HJM, Pieter JPH; tREACH group investigators. Nathalie LM, et al. Rheumatology (Oxford). 2021 Dec 1;60(12):5765-5774. doi: 10.1093/rheumatology/keab251. Rheumatology (Oxford). 2021. PMID: 33725091 Free PMC article. Clinical Trial.

2

Use of risk stratification to target therapies in patients with recent onset arthritis; design of a prospective randomized multicenter controlled trial.

Claessen SJ, Hazes JM, Huisman MA, van Zeben D, Luime JJ, Weel AE. Claessen SJ, et al. BMC Musculoskelet Disord. 2009 Jun 18;10:71. doi: 10.1186/1471-2474-10-71. BMC Musculoskelet Disord. 2009. PMID: 19538718 Free PMC article. Clinical Trial.

3

Inadequate response to treat-to-target methotrexate therapy in patients with new-onset rheumatoid arthritis: development and validation of clinical predictors.

Teitsma XM, Jacobs JWG, Welsing PMJ, de Jong PHP, Hazes JMW, Weel AEAM, Pethö-Schramm A, Borm MEA, van Laar JM, Lafeber FPJG, Bijlsma JWJ. Teitsma XM, et al. Ann Rheum Dis. 2018 Sep;77(9):1261-1267. doi: 10.1136/annrheumdis-2018-213035. Epub 2018 May 14. Ann Rheum Dis. 2018. PMID: 29760159 Clinical Trial.

4

Randomised comparison of initial triple DMARD therapy with methotrexate monotherapy in combination with low-dose glucocorticoid bridging therapy; 1-year data of the tREACH trial.

de Jong PH, Hazes JM, Han HK, Huisman M, van Zeben D, van der Lubbe PA, Gerards AH, van Schaeybroeck B, de Sonnaville PB, van Krugten MV, Luime JJ, Weel AE. de Jong PH, et al. Ann Rheum Dis. 2014 Jul;73(7):1331-9. doi: 10.1136/annrheumdis-2013-204788. Epub 2014 May 1. Ann Rheum Dis. 2014. PMID: 24788619 Free PMC article. Clinical Trial.

5

Effect of methotrexate use and erythrocyte methotrexate polyglutamate on glycosylated hemoglobin in rheumatoid arthritis.

de Rotte MC, de Jong PH, den Boer E, Pluijm SM, Özcan B, Weel AE, Lindemans J, Hazes JM, de Jonge R. de Rotte MC, et al. Arthritis Rheumatol. 2014 Aug;66(8):2026-36. doi: 10.1002/art.38652. Arthritis Rheumatol. 2014. PMID: 24692301 Clinical Trial.

6

Association of low baseline levels of erythrocyte folate with treatment nonresponse at three months in rheumatoid arthritis patients receiving methotrexate.

de Rotte MC, de Jong PH, Pluijm SM, Calasan MB, Barendregt PJ, van Zeben D, van der Lubbe PA, de Sonnaville PB, Lindemans J, Hazes JM, de Jonge R. de Rotte MC, et al. Arthritis Rheum. 2013 Nov;65(11):2803-13. doi: 10.1002/art.38113. Arthritis Rheum. 2013. PMID: 24166792 Clinical Trial.

7

Brief Report: to squeeze or not to squeeze, that is the question! Optimizing the disease activity score in 28 joints by adding the squeeze test of metatarsophalangeal joints in early rheumatoid arthritis.

de Jong PH, Weel AE, de Man YA, Huisman AM, Gerards AH, van Krugten MV, Luime JJ, Hazes JM. de Jong PH, et al. Arthritis Rheum. 2012 Oct;64(10):3095-101. doi: 10.1002/art.34568. Arthritis Rheum. 2012. PMID: 22673898 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Results by year